Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedixTSE:331A 20 Return-on-Tangible-Equity is 17.77% as of Mar. 2026, which is 45% below its 10-year median of 32.38. GuruFocus rates TSE:331A with a GF Score™ of 20/100. The stock has 4 warning signs investors should review. Among 864 Media - Diversified companies, Medix ranks better than 68.87% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Medix's annualized net income for the quarter that ended in Mar. 2026 was 円546 Mil. Medix's average shareholder tangible equity for the quarter that ended in Mar. 2026 was 円3,072 Mil. Therefore, Medix's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 17.77%.
The historical rank and industry rank for Medix's Return-on-Tangible-Equity or its related term are showing as below:
TSE:331A'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 13.76 Med: 32.38 Max: 56.99
Current: 13.96
During the past 4 years, Medix's highest Return-on-Tangible-Equity was 56.99%. The lowest was 13.76%. And the median was 32.38%.
TSE:331A's Return-on-Tangible-Equity is ranked better than 68.87% of 864
companies
in the Media - Diversified industry
Industry Median: 5.44
vs TSE:331A: 13.96
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Medix Return-on-Tangible-Equity Related Terms
Medix Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Medix's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:331A vs APP, OMC, TTD: Return-on-Tangible-Equity Comparison
For the Advertising Agencies subindustry, Medix's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medix Return-on-Tangible-Equity vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Medix's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Medix's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 17.77% mean?
Medix (TSE:331A) has a Return-on-Tangible-Equity of 17.77% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Medix and its competitors. This is 45% below median its historical median of 32.38. Over the past decade, Medix's Return-on-Tangible-Equity has ranged from 13.76 to 56.99. According to the industry distribution chart, Medix ranks #269 out of 864 companies in the Media - Diversified industry, placing it in the top 31.1%.
Is Medix's Return-on-Tangible-Equity too high?
Medix's current Return-on-Tangible-Equity of 17.77% is 45% below median its 10-year median of 32.38. Over the past 10 years, this metric has ranged from a low of 13.76 to a high of 56.99. The Media - Diversified industry median Return-on-Tangible-Equity is 5.44. Medix's value of 17.77% is 226.7% above this industry median. Based on the distribution chart, Medix ranks #269 out of 864 companies in the Media - Diversified industry, which is above the industry midpoint. Overall, Medix has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Medix's Return-on-Tangible-Equity compare to APP and OMC?
According to the Media - Diversified industry distribution chart, Medix ranks #269 out of 864 companies for Return-on-Tangible-Equity. This puts Medix in the upper half of its industry. The industry median Return-on-Tangible-Equity is 5.44. Medix's value of 17.77% is 226.7% above this benchmark. Historically, Medix's own Return-on-Tangible-Equity has ranged from 13.76 to 56.99 over the past decade. While the company's 10-year median is 32.38 vs. the industry median of 5.44, Medix has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Media - Diversified company?
The median Return-on-Tangible-Equity among Media - Diversified companies is 5.44, based on 864 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medix's current Return-on-Tangible-Equity of 17.77% is 226.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Medix and its competitors. For the Media - Diversified industry, the median Return-on-Tangible-Equity is 5.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medix's current Return-on-Tangible-Equity is 17.77%, which is 45% below median its own 10-year median of 32.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medix stock overvalued right now?
Medix (TSE:331A) has a current Return-on-Tangible-Equity of 17.77%. The current Return-on-Tangible-Equity is 17.77%, which is 45% below median its 10-year median of 32.38 and 226.7% above the Media - Diversified industry median of 5.44. Medix's overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Medix (TSE:331A), the current Return-on-Tangible-Equity is 17.77% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medix Inc is an internet advertising agency that places the utmost importance on understanding its clients' business models deeply and helping them solve problems over the medium to long term. It is engaged in Digital marketing services including creative design and production, data parsing and analysis, and Internet advertising services. The company provides services in the digital marketing field to clients in various lines and industries.
20GF Score
Get the complete analysis for TSE:331A
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:331A has been successfully added to your 
